ICYMI, this week we had stories from the about precision medicine, FDA's newest approval, and more.
Mobile screening and education initiatives can help bridge gaps in both patient knowledge and access to care.
A single lesson made an impact on high school students' knowledge and behavior when it came to sun protection.
A Portuguese study examined the association between the use of anti-aging products and the self-esteem of the women who used them.
Matthew Zirwas, MD, shares his step-by-step pearls for quelling this pruritic skin condition.
Verbal abuse, discrimination towards doctors is common, study finds.
This week's edition of the Mainstream Patients features stories about the top 10 best acne-fighting ingredients and medications in 2022, Bill Nye talks not using oil on the scalp, and more.
Recent data tracks the first realization of precision medicine for patients with psoriasis.
Dermavant’s new topical treatment for plaque psoriasis in adults was approved by the FDA this morning.
Mindera Health and a national health insurance company launched a pilot program to improve moderate-to-severe psoriasis management with precision medicine.
AMA, Joint Commission aim to improve outcomes for marginalized patients.
In this week’s Pointers with Dr Portela, the 208SkinDoc dives into the reason why his channel exists and how he plans to help the average patient watching his YouTube videos.
Medical staff, pushed past their breaking point, say something has to change.
AI’s ability to quickly process and interpret large quantities of health data is a valuable tool for physicians.
Study finds financial, cultural barriers to care common among rural residents.
In this drug pipeline interview, Christopher Bunick, MD, PhD, discusses what is innovative in future acne treatment options, what research is happening, and what potential approvals the dermatology space has to look forward to.
Learn to discern the best pain-mitigation strategies for each patient, based on research and personal experience.
Chargemaster lists may encourage patients to shop around for services, but the authors of this report said the implications of this change for dermatology are not well-defined.
American Hospital Association requesting a task force from the justice department to investigate commercial health insurance companies in the Medicare Advantage program.